MERCK SHARP & DOHME LLC: $156M Department of Health and Human Services Contract
Summary
Merck & Co. ($MRK) received a $156M definitive contract from HHS/ASPR for Ervebo (Ebola vaccine) procurement over 10 years. The contract is small relative to Merck's $60.1B revenue, representing a stable but minor revenue stream. No direct legislative connection was identified.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Merck won a $156M, 10-year contract for Ebola vaccine procurement, but it is too small to significantly impact financials.
- 2.The contract reinforces Merck's position in biodefense but offers no transformational catalyst.
- 3.No direct legislative tailwind was identified; the award is a routine procurement under HHS preparedness authority.
Market Implications
The contract is a small, stable revenue stream for Merck. It does not alter the company's investment thesis or competitive dynamics. Other vaccine pure-plays like $NVAX or $MRNA are not directly affected. The impact is limited to Merck, and even then, it is negligible.
Full Analysis
- The contract: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., was awarded a $156M definitive contract by the Department of Health and Human Services, Office of Assistant Secretary for Preparedness and Response, for procurement of Ervebo, an Ebola vaccine. The contract runs from 2024 to 2034. 2) The public company beneficiary is Merck & Co., Inc.. With annual revenue of $60.1B (FY2025), the $156M contract (~$15.6M/year) represents a negligible 0.03% of revenue. This is a low-impact, routine contract for Merck. 3) No related bills from the provided list directly connect to this contract. The contract falls under the Public Health Service Act's biodefense provisions, but no specific bill authorizing this exact procurement was identified. 4) Supply chain beneficiaries are not clearly identifiable from the contract data. However, contract manufacturing organizations (CMOs) like Thermo Fisher Scientific ($TMO) or Catalent ($CTLT) could potentially benefit if Merck outsources production, but this is speculative. The contract is likely for the finished vaccine product. 5) Historically, government vaccine procurement contracts provide stable, low-margin revenue streams. Similar contracts for pandemic preparedness (e.g., HHS contracts for COVID-19 vaccines) have been larger but follow a similar pattern. For Merck, this is a minor but consistent addition to its vaccine segment.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
MERCK SHARP & DOHME LLC: $156M Department of Health and Human Services Contract
MERCK SHARP & DOHME LLC: $2.4B Department of Health and Human Services Contract Vehicle
MERCK SHARP & DOHME LLC: $1.8B Department of Health and Human Services Contract Vehicle
End the Vaccine Carveout Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Contract Details
Recipient
MERCK SHARP & DOHME LLC
Award Amount
$155,843,515
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DEFINITIVE CONTRACT
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →